Recap: Amphastar Pharma Q3 Earnings

Amphastar Pharma AMPH reported its Q3 earnings results on Wednesday, November 8, 2023 at 04:05 PM.

Here's what investors need to know about the announcement.

Amphastar Pharma beat estimated earnings by 66.67%, reporting an EPS of $1.15 versus an estimate of $0.69.

Revenue was up $60.43 million from the same period last year.

Last quarter the company beat on EPS by $0.09 which was followed by a 4.29% drop in the share price the next day.

Here's a look at Amphastar Pharma's past performance:

Quarter	Q2 2023	Q1 2023	Q4 2022	Q3 2022
EPS Estimate	0.56	0.48	0.41	0.39
EPS Actual	0.65	0.62	0.73	0.38
Revenue Estimate	137.37M	136.33M	126.98M	126.37M
Revenue Actual	145.71M	140.02M	135.02M	120.13M

To track all earnings releases for Amphastar Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar